Severe Skin Rash Associated with Atazanavir

Three cases of severe rash associated with the use of atazanavir are described. In all cases, the rash was maculopapular and pruritic. Rash onset occurred eight to 11 days after initiation of therapy, and resolved with atazanavir discontinuation. Clinicians prescribing atazanavir should be aware of...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew Walkty, Dick Smith, Bernie Lopko, Ken Kasper
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2009/721956
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409892970921984
author Andrew Walkty
Dick Smith
Bernie Lopko
Ken Kasper
author_facet Andrew Walkty
Dick Smith
Bernie Lopko
Ken Kasper
author_sort Andrew Walkty
collection DOAJ
description Three cases of severe rash associated with the use of atazanavir are described. In all cases, the rash was maculopapular and pruritic. Rash onset occurred eight to 11 days after initiation of therapy, and resolved with atazanavir discontinuation. Clinicians prescribing atazanavir should be aware of this potential adverse effect.
format Article
id doaj-art-7fa2610e1cf54a24bb9c42003b7b1a70
institution Kabale University
issn 1712-9532
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-7fa2610e1cf54a24bb9c42003b7b1a702025-08-20T03:35:20ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322009-01-01201e10e1210.1155/2009/721956Severe Skin Rash Associated with AtazanavirAndrew Walkty0Dick Smith1Bernie Lopko2Ken Kasper3Department of Medicine, Health Sciences Centre, CanadaNine Circles Community Health Centre, Winnipeg, Manitoba, CanadaNine Circles Community Health Centre, Winnipeg, Manitoba, CanadaDepartment of Medicine, Health Sciences Centre, CanadaThree cases of severe rash associated with the use of atazanavir are described. In all cases, the rash was maculopapular and pruritic. Rash onset occurred eight to 11 days after initiation of therapy, and resolved with atazanavir discontinuation. Clinicians prescribing atazanavir should be aware of this potential adverse effect.http://dx.doi.org/10.1155/2009/721956
spellingShingle Andrew Walkty
Dick Smith
Bernie Lopko
Ken Kasper
Severe Skin Rash Associated with Atazanavir
Canadian Journal of Infectious Diseases and Medical Microbiology
title Severe Skin Rash Associated with Atazanavir
title_full Severe Skin Rash Associated with Atazanavir
title_fullStr Severe Skin Rash Associated with Atazanavir
title_full_unstemmed Severe Skin Rash Associated with Atazanavir
title_short Severe Skin Rash Associated with Atazanavir
title_sort severe skin rash associated with atazanavir
url http://dx.doi.org/10.1155/2009/721956
work_keys_str_mv AT andrewwalkty severeskinrashassociatedwithatazanavir
AT dicksmith severeskinrashassociatedwithatazanavir
AT bernielopko severeskinrashassociatedwithatazanavir
AT kenkasper severeskinrashassociatedwithatazanavir